Center for Infectious Disease Research and Policy

What Center for Infectious Disease Research and Policy does

CIDRAP (Center for Infectious Disease Research and Policy) is a public health information and research center housed within the University of Minnesota's Research and Innovation Office in Minneapolis, founded in 2001. The organization operates as a web-based infectious disease news and information platform that aggregates, analyzes, and publishes content on emerging and re-emerging infectious diseases, maintaining dedicated topic coverage and RSS feeds for more than 60 disease areas spanning COVID-19, influenza, antimicrobial resistance, Ebola, measles, fungal infections, and others. Its core products include the CIDRAP News platform, the Osterholm Update podcast hosted by Director Dr. Michael Osterholm and reporter Chris Dall, and specialized vaccine R&D roadmaps for influenza and coronaviruses.

CIDRAP's business model is non-commercial and grant-funded: the center provides free public access to its content and is supported by unrestricted financial contributions from a small set of named underwriters, including the Bentson Foundation (Principal Underwriter), Unorthodox Philanthropy (Leading Underwriter), and the Albert Victor Ravenholt Fund (Supporting Underwriter). It generates no disclosed product revenue, subscription fees, or advertising income, and its primary monetization mechanism is philanthropic and institutional sponsorship. The center serves three primary audiences: public health professionals (epidemiologists, healthcare workers, researchers), the general public seeking accessible evidence-based health information, and government and policy makers who use CIDRAP content for situational awareness and policy development.

The organization's distribution architecture is multi-channel and includes its primary website (cidrap.umn.edu), email newsletters across multiple topic streams, dedicated YouTube channels, X/Twitter and Bluesky social accounts, and topic-specific RSS feeds. Strategic product extensions include the Vaccine Integrity Project (launched April 24, 2025) for evidence-based vaccine information in partnership with the Evidence Collective, a joint Public Health Alerts section with NEJM Evidence for rapid-response publications, and an expanding set of roadmap and tracker products for vaccine R&D intelligence. The organization is led by Director Michael Osterholm, with a small team sized between 11 and 50 employees, and has no disclosed venture, private equity, or public market financing.

Name

Center for Infectious Disease Research and Policy

Legal name

Center for Infectious Disease Research and Policy

Website

https://cidrap.umn.edu

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

CIDRAP is a University of Minnesota-affiliated public health information center that publishes evidence-based news, analysis, and vaccine R&D tracking on more than 60 infectious disease topics, serving public health professionals, policy makers, and the general public through free digital and podcast channels.

Ownership category

akta.pro rank

Product category

Public Health Information Services

akta.pro primary industry

Disease & Condition Surveillance Programs (HLAJANAB)

Keywords

• Infectious disease research
• Public health news
• Vaccine policy analysis
• Epidemic preparedness
• Antimicrobial resistance tracking

Headquarters

HQ city

Minneapolis

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Distribution channels5 records

Marketing channels9 records

Core offering

CIDRAP is a public health information and research center that produces evidence-based news, analysis, and policy resources on infectious diseases. It delivers daily news articles, expert podcasts (Osterholm Update), newsletters, and dedicated topic coverage spanning over 60 disease areas including COVID-19, influenza, Ebola, and antimicrobial resistance. It also operates specialized vaccine R&D roadmap platforms and the Vaccine Integrity Project.

Product overview

CIDRAP (Center for Infectious Disease Research and Policy) operates as a news and information platform focused on infectious disease research, providing comprehensive coverage through its main CIDRAP News platform and specialized topic sections. The core offerings include the Osterholm Update Podcast hosted by Dr. Michael Osterholm, and the CIDRAP Newsletter delivering daily and periodic updates. CIDRAP also manages specialized roadmaps including the Coronavirus Vaccines Roadmap (CVR) and Influenza Vaccines Roadmap (IVR), which provide R&D progress tracking and technology landscapes for vaccine development. The Vaccine Integrity Project supports evidence-based vaccine information, while the Public Health Alerts (joint with NEJM Evidence) provide rapid response publications. The organization offers topic-specific RSS feeds covering over 80 infectious disease categories from Acute Flaccid Myelitis to Zika. Social media presence includes YouTube channels for antimicrobial stewardship and CWD content, Bluesky accounts, and X (Twitter) accounts for news and specific topics. CIDRAP is part of the University of Minnesota's Research and Innovation Office.

Differentiator

Problem solved

Functional benefit

Brands

• Osterholm Update: Weekly podcast providing discussion and analysis on the latest infectious disease developments by Dr. Michael Osterholm and Chris Dall
• Vaccine Integrity Project (VIP)

Products and services

• CIDRAP News

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• GIDEON: GIDEON is an infectious disease database and outbreak tracking platform used by clinicians, epidemiologists, and public health professionals. Comparable to CIDRAP's roadmap-style R&D tracking products, with a parallel emphasis on structured infectious disease intelligence for professionals.
• HealthMap: HealthMap aggregates disease outbreak surveillance data from multiple sources worldwide using algorithmic and human curation. Comparable to CIDRAP because it sits at the intersection of public health surveillance and information dissemination, and competes for the same public-health-professional audience that tracks infectious disease developments.
• ProMED-mail: The Program for Monitoring Emerging Diseases is a long-running infectious disease surveillance and outbreak reporting network covering global public health threats. It is the closest direct comparison to CIDRAP's disease-topic surveillance and rapid outbreak alert function, operating on a similar nonprofit, globally distributed curation model.

Others

• Infectious Diseases Society of America (IDSA): IDSA is the largest professional society representing infectious disease physicians and publishes clinical guidelines, policy positions, and outbreak commentary. It addresses a closely overlapping audience and mission (infectious disease policy and practice) and serves as an enabling ecosystem organization rather than a direct content competitor.

Broad incumbents

• STAT News: STAT is a large, well-funded health and science news outlet with deep coverage of infectious disease, vaccines, and public health policy. It overlaps with CIDRAP's news and analysis function while operating at a much larger commercial scale and broader editorial scope.
• European Centre for Disease Prevention and Control (ECDC): The EU's public health agency issues surveillance reports, outbreak risk assessments, and infectious disease guidance across Europe. It is comparable to CIDRAP as a public-facing infectious disease intelligence body, but is a government agency with a regional rather than global remit and a much larger institutional mandate.
• The Lancet Infectious Diseases: A leading peer-reviewed journal focused specifically on infectious disease, including outbreak reporting and vaccine policy commentary. It targets the same clinician/researcher audience as CIDRAP but operates as a subscription academic journal rather than an open-access news and intelligence platform.
• NEJM (New England Journal of Medicine): NEJM publishes peer-reviewed research and the 'NEJM Evidence' section that is now jointly producing Public Health Alerts with CIDRAP. The two share an audience of public-health professionals and have an active content partnership, but NEJM is a much larger, journal-based incumbent covering all of medicine.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/CIDRAP
• YouTubeyoutube.com/user/CIDRAPASP
• LinkedInlinkedin.com/company/center-for-infectious-disease-research-and-policy-cidrap-?original_referer=https%3A%2F%2Fwww.google.com%2F

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Center for Infectious Disease Research and Policy